Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about VC-Backed AI Startup Seeks To Accelerate Drug Discovery
Venture Capital

VC-Backed AI Startup Seeks To Accelerate Drug Discovery

by venturebeat.com posted 1year ago 273 views
Atomwise, which uses artificial intelligence to accelerate drug discovery for diseases like Ebola, multiple sclerosis, and leukemia, today announced the launch of its Artificial Intelligence Molecular Screen (AIMS) program. To date, it's backed by Data Collective, Khosla Ventures, DFJ, AME Cloud Ventures, Draper Associates, Y Combinator and OS Fund.